Ross V. ChikarmaneMoney in PoliticsA data-driven profile on major sources of campaign financing for U.S. Congressional & Presidential elections and their influence on…17 min read·May 13, 2022----
Ross V. ChikarmaneA Memoir on Building Hopkins Biotech PodcastHow we built the Hopkins Biotech Podcast — based out of Johns Hopkins School of Medicine — and grew it from a simple idea to a program…23 min read·Mar 19, 2022----
Ross V. ChikarmanePhD Career Prospects by the NumbersA data-driven profile on the types of work that STEM PhDs pursue and their pay scales, based on employment statistics from the National…8 min read·Nov 6, 2021----
Ross V. ChikarmaneinThe StartupBiotech Investment Surges in 2020In honor of the last trading day of 2020, let’s review this year in biotech investing.6 min read·Dec 31, 2020--1--1
Ross V. ChikarmaneinThe StartupFoghorn Therapeutics Breaks New Ground in Cancer EpigeneticsOriginally published on December 2, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)5 min read·Dec 25, 2020----
Ross V. ChikarmaneinThe StartupNext Generation Cancer Diagnostics Revolutionize Patient CareOriginally published on October 5, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)7 min read·Dec 25, 2020----
Ross V. ChikarmaneHow to Master a New TechniqueOriginally published on August 3, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)6 min read·Dec 25, 2020----
Ross V. ChikarmaneWhy Leave Career Fulfillment Up to Chance?Originally published on June 24, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) to promote the Hopkins Biotech Podcast, which we…5 min read·Dec 25, 2020--1--1
Ross V. ChikarmaneEvery Challenge Is an OpportunityOriginally published on April 21, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)5 min read·Dec 25, 2020----
Ross V. ChikarmaneAn Alzheimer’s Drug Rises from the AshesOriginally published on April 11, 2020 in Hopkins Biotech Network’s newsletter The Transcript (link)10 min read·Dec 25, 2020----